{
    "2021-12-29": [
        [
            {
                "time": "",
                "orginal_text": "复锐医疗科技(01696)控股股东购买14.16万股公司股份",
                "features": {
                    "keywords": [
                        "复锐医疗科技",
                        "控股股东",
                        "购买",
                        "股份"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "开拓药业产品研发遇挫，另一家合作公司默沙东“中枪”",
                "features": {
                    "keywords": [
                        "开拓药业",
                        "产品研发",
                        "遇挫",
                        "默沙东"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "新浪医药年度盘点丨合久必分？2021医药行业十大拆分剥离动态 有人为“升级” 有人为“保命”",
                "features": {
                    "keywords": [
                        "新浪医药",
                        "年度盘点",
                        "拆分剥离",
                        "升级",
                        "保命"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "复星医药(02196)：“18复药03”注销未转售债券金额9.91亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "18复药03",
                        "注销",
                        "债券"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "复星医药(02196)：2021年度内董事变动后公司治理结构符合法律规定",
                "features": {
                    "keywords": [
                        "复星医药",
                        "董事变动",
                        "治理结构",
                        "法律规定"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "恒指收跌0.83%，恒生科技指数创历史低位",
                "features": {
                    "keywords": [
                        "恒指",
                        "收跌",
                        "恒生科技指数",
                        "历史低位"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "上海复星医药集团：公司董事发生变动 董监高成员变化",
                "features": {
                    "keywords": [
                        "上海复星医药集团",
                        "董事变动",
                        "董监高成员变化"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "上海复星医药集团：“18复药03”完成转售",
                "features": {
                    "keywords": [
                        "上海复星医药集团",
                        "18复药03",
                        "完成转售"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "新冠“神药”临床结果未达预期，开拓药业否认失败，国内还有5款口服药在研",
                "features": {
                    "keywords": [
                        "新冠",
                        "神药",
                        "临床结果",
                        "开拓药业",
                        "口服药"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "港股异动 | 复星医药跌5% 子公司终止万格列净片药品临床试验及后续开发",
                "features": {
                    "keywords": [
                        "港股",
                        "复星医药",
                        "子公司",
                        "终止",
                        "临床试验"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "[港股通]复星医药(02196)跌逾4% 子公司终止药品临床试验",
                "features": {
                    "keywords": [
                        "港股通",
                        "复星医药",
                        "子公司",
                        "终止",
                        "药品临床试验"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}